Satellos Bioscience
Satellos is a biopharmaceutical company that develops small molecule drugs for the treatment of degenerative disease and muscle wasting disorders.
Business Model:
Revenue: $0
Employees: 1-10
Rankings
Industries / Tags:
Detailed Satellos Bioscience Information
Satellos Bioscience was acquired by
iCo Therapeutics.
The acquisition happend on 2021-03-22.
Details of the transaction were not public
Acquirer
Geographic Data
Address: 65 Front Street E
City: Toronto
State: ontario
Zip: M4J
Country: CA
Financial Info
Stage:
grant
Raised Last:
$1M
Raised Total:$1M
Social
Metrics
9,293,688Website Global Rank
312Website Monthly Traffic
Twitter Followers
Description
Satellos is a biopharmaceutical company that develops small molecule drugs for the treatment of degenerative disease and muscle wasting disorders.
Contact Phone:
Contact Email:
Satellos Bioscience went public on the OTCMKTS
Listed Exchange:
OTCMKTS
Ticker Symbol:
MSCLF
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 1/2021 | Equity | 1 | $1M |
Parent Project Muscular Dystrophy Parent Project Muscular Dystrophy Parent Project Muscular Dystrophy |
10/2022 | IPO | - | 10/2022 | IPO | - |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
